Common Genetic Polymorphisms and Haplotypes of Fibrinogen Alpha, Beta, and Gamma Chains Affect Fibrinogen Levels and the Response to Proinflammatory Stimulation in Myocardial Infarction Survivors. The AIRGENE Study

Journal of the American College of Cardiology

Volumn 52, Issue 11, 2008, Pages 941-952

  Jacquemin, Bénédicte ^a   Antoniades, Charalambos ^b,c   Nyberg, Fredrik ^d,e   Plana, Estel ^a   Müller, Martina ^g,h   Greven, Sonja ^g,h,i   Salomaa, Veikko ^j   Sunyer, Jordi ^a,k   Bellander, Tom ^d   Chalamandaris, Alexandros Georgios ^b   Pistelli, Ricardo ^l   Koenig, Wolfgang ^f   Peters, Annette ^g  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

^f UNIVERSITY HOSPITAL ULM   (Germany)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^k UNIVERSITAT POMPEU FABRA   (Spain)

^l CATHOLIC UNIVERSITY   (Italy)

more..

Author keywords

fibrinogen; genetics; inflammation; myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; FIBRINOGEN ALPHA; FIBRINOGEN BETA; FIBRINOGEN GAMMA; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; EUROPE; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENE CLUSTER; GENETIC ANALYSIS; GENETIC VARIABILITY; HAPLOTYPE; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVOR;

AGED; C-REACTIVE PROTEIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FIBRINOGEN; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 50349095252     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.06.016     Document Type: Article

References (34)

1. Danesh J., Lewington S., Thompson S.G., et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
2. Mosesson M.W., Siebenlist K.R., and Meh D.A. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936 (2001) 11-30
3. Naito M., Hayashi T., Kuzuya M., Funaki C., Asai K., and Kuzuya F. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis 83 (1990) 9-14
4. Yee K.O., and Schwartz S.M. Why atherosclerotic vessels narrow: the fibrin hypothesis. Thromb Haemost 82 (1999) 762-771
5. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 89 (2003) 601-609
6. Hermida C., Calvo C., Ayala D.E., et al. Seasonal variation of fibrinogen in dipper and nondipper hypertensive patients. Circulation 108 (2003) 1101-1107
7. Scarabin P.Y., Aillaud M.F., Amouyel P., et al. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction-the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost 80 (1998) 749-756
8. Voetsch B., and Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 24 (2004) 216-229
9. Yu S., Sher B., Kudryk B., and Redman C.M. Fibrinogen precursors. Order of assembly of fibrinogen chains. J Biol Chem 259 (1984) 10574-10581
10. Kathiresan S., Yang Q., Larson M.G., et al. Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 26 (2006) 1405-1412
11. Green F.R. Fibrinogen polymorphisms and atherothrombotic disease. Ann N Y Acad Sci 936 (2001) 549-559
12. Verschuur M., de Jong M., Felida L., de Maat M.P., and Vos H.L. A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphism. J Biol Chem 280 (2005) 16763-16771
13. Behague I., Poirier O., Nicaud V., et al. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation 93 (1996) 440-449
14. Gardemann A., Schwartz O., Haberbosch W., et al. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. Thromb Haemost 77 (1997) 1120-1126
15. AIRGENE Study Group, Peters A., Scheider A., Greven A., et al. Air pollution and inflammatory response in myocardial infarction survivors: gene-environment-interactions in a high-risk group. Study design of the AIRGENE study. Inhal Toxic 19 Suppl 1 (2007) 161-175
16. National Centre for Biotechnology. National Centre for Biotechnology SNP database Build 124, based on NCBI Human Genome Build 35.1. January 6, 2005. http://www.ncbi.nlm.nih.gov/SNP/ Accessed January 6, 2005
17. Innate Immunity Program for Genomic Applications. IIPGA database. http://innateimmunity.net/ Accessed January 6, 2005
18. SeattleSNPs Program for Genomic Applications. http://pga.gs.washington.edu/ Accessed January 6, 2005
19. Weidinger S., Klopp N., Wagenpfeil S., et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 41 (2004) 658-663
20. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
21. Greven S., Kuchenhoff H., and Peters A. Additive mixed models with P-splines. In: Hinde J., Einbeck J., and Newell J. (Eds). Proceedings of the 21st International Workshop on Statistical Modelling (2006), Statistical Modelling Society, Amsterdam 201-207
22. Li J., and Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95 (2005) 221-227
23. Tousoulis D., Antoniades C., and Stefanadis C. Assessing inflammatory status in cardiovascular disease. Heart 93 (2007) 1001-1007
24. Roy S.N., Mukhopadhyay G., and Redman C.M. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 265 (1990) 6389-6393
25. Thomas A.E., Green F.R., Kelleher C.H., et al. Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 65 (1991) 487-490
26. van't Hooft F.M., von Bahr S.J., Silveira A., Iliadou A., Eriksson P., and Hamsten A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 19 (1999) 3063-3070
27. Friedlander Y., Kark J.D., Sinnreich R., Basso F., and Humphries S.E. Combined segregation and linkage analysis of fibrinogen variability in Israeli families: evidence for two quantitative-trait loci, one of which is linked to a functional variant (-58G > A) in the promoter of the alpha-fibrinogen gene. Ann Hum Genet 67 (2003) 228-241
28. Cook D.G., Cappuccio F.P., Atkinson R.W., et al. Ethnic differences in fibrinogen levels: the role of environmental factors and the beta-fibrinogen gene. Am J Epidemiol 153 (2001) 799-806
29. de Maat M.P. Effects of diet, drugs, and genes on plasma fibrinogen levels. Ann N Y Acad Sci 936 (2001) 509-521
30. Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S.E., Abildgaard S., Schnohr P., and Nordestgaard B.G. A common mutation (G-455-> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest 99 (1997) 3034-3039
31. Zerjal T., Beckman L., Beckman G., et al. Geographical, linguistic, and cultural influences on genetic diversity: Y-chromosomal distribution in Northern European populations. Mol Biol Evol 18 (2001) 1077-1087
32. Mavri A., Guzic-Salobir B., Salobir-Pajnic B., Keber I., Stare J., and Stegnar M. Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease. Blood Coagul Fibrinolysis 12 (2001) 359-365
33. Afilalo J., Duque G., Steele R., Jukema J.W., de Craen A.J., and Eisenberg M.J. Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol 51 (2008) 37-45
34. Undas A., Brummel-Ziedins K.E., and Mann K.G. Statins and blood coagulation. Arterioscler Thromb Vasc Biol 25 (2005) 287-294